Evolus(US:EOLS)2025-11-05 21:12Financial Performance - Total net revenue for Q3 2025 was $69.0 million, a 13% increase from Q3 2024, driven by the introduction of Evolysse and growth in global Jeuveau revenue [5]. - Global Jeuveau net revenue reached $63.2 million for Q3 2025, up from $59.7 million in Q2 2025, reflecting sequential growth that outperformed typical seasonal trends [5]. - Evolysse generated $5.7 million in revenue for Q3 2025, marking the strongest hyaluronic acid filler debut in over a decade [5]. - Product revenue for Q3 2025 reached $68.967 million, a 14.7% increase from $60.164 million in Q3 2024 [23]. - Total net revenues for the nine months ended September 30, 2025, were $206.876 million, compared to $187.327 million for the same period in 2024, reflecting a growth of 10.5% [23]. Profitability and Loss - The company expects to achieve positive non-GAAP operating income of $5 million to $7 million in Q4 2025, remaining on track for sustainable annual profitability beginning in 2026 [5]. - GAAP loss from operations for Q3 2025 was $11.5 million, an improvement from $15.5 million in Q3 2024 [7]. - The net loss for Q3 2025 was $15.737 million, compared to a net loss of $19.170 million in Q3 2024, showing an improvement of 17.5% [23]. - Non-GAAP loss from operations for Q3 2025 was $3.079 million, an improvement from a loss of $6.738 million in Q3 2024 [33]. - The company reported a comprehensive loss of $15.275 million for Q3 2025, compared to a comprehensive loss of $19.258 million in Q3 2024 [23]. Guidance and Future Plans - The company reaffirms its 2025 net revenue guidance of $295 million to $305 million, representing 11% to 15% growth over 2024 results [8]. - Evolus plans to launch Evolysse Sculpt in the U.S. in 2026 and Evolysse Lips in 2027, with a target of $700 million in total net revenue by 2028 [8]. Customer and Market Growth - Total purchasing accounts increased by nearly 500 in Q3 2025, with over 17,000 customers having purchased from Evolus since launch [6]. - Evolus Rewards consumer loyalty program members grew by over 79,000 during the quarter, surpassing 1.3 million, representing a total increase of 34% compared to Q3 2024 [9]. Expenses and Margins - Gross profit margin for Q3 2025 was 66.5%, while adjusted gross profit margin was 67.6% [7]. - Gross profit margin for Q3 2025 was 66.5%, down from 68.9% in Q3 2024 [29]. - Operating expenses for Q3 2025 were $57.341 million, slightly down from $57.572 million in Q3 2024 [31]. - Research and development expenses for the nine months ended September 30, 2025, were $6.095 million, compared to $6.742 million for the same period in 2024 [23]. Cash and Liabilities - Cash and cash equivalents decreased to $43.523 million as of September 30, 2025, from $86.952 million at the end of 2024 [25]. - Total liabilities increased to $247.757 million as of September 30, 2025, compared to $227.047 million at the end of 2024 [25].